Explain Pain in Fibromyalgia Patients
Fibromyalgia
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring Fibromyalgia, Patient education, Central sensitization
Eligibility Criteria
Inclusion Criteria:
- American College of Rheumatology classification criteria for FM, both 1990 and 2010
- Reported average pain intensity ≥ 4 on a 0 to 10 cm visual analogue scale based on 1 week of daily pain diaries
- On stable doses of medications for FM ≥ 4 weeks
Exclusion Criteria:
- Suffer from an inflammatory rheumatic conditions
- Have a planned elective surgery during the study period
- Have ongoing unresolved disability claims
- Experience symptoms of bipolar disorder, major depressive disorder, panic disorder, or psychosis
- Do not speak Spanish fluently
Sites / Locations
- Unviversidad de Alcalá
- Universidad Rey Juan Carlos
- Universidad CEU Cardenal Herrera
- Universidad de Valencia
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
Experimental
Educational program Control Group
Educational program High Dose Group
Educational program Diluted Low Dose Group
Educational program Concentrated Low Dose Group
6 group sessions: 1h/session - 1 session/week - 6 weeks 4 first sessions: relaxation exercises 2 last sessions: talk about medical issues (drugs, nutrition, importance of sleep...)
6 group sessions: 1h/session - 1 session/week - 6 weeks 6 sessions: 45 minutes of educational sessions about the neurophysiology of pain + 15 minutes of relaxation exercises
6 group sessions: 1h/session - 1 session/week - 6 weeks 6 sessions: 45 minutes of educational sessions about the neurophysiology of pain + 15 minutes of relaxation exercises
6 group sessions: 1h/session - 1 session/week - 6 weeks 4 first sessions: relaxation exercises 2 last sessions: educational sessions about the neurophysiology of pain